omnopon 15.4, 1.2, milligram solution for injection
martindale pharmaceuticals ltd - morphine hydrochloride dihydrocodeine hydrochloride papaverine hydrochloride - solution for injection - 15.4, 1.2, milligram
movapo pfs apomorphine hydrochloride hemihydrate 50mg/10ml solution for subcutaneous infusion pre-filled syringe
stada pharmaceuticals australia pty ltd - apomorphine hydrochloride hemihydrate, quantity: 50 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; hydrochloric acid - movapo pfs is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine injection should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.
omnopon solution for injection 15.4, 1.2, milligram
martindale pharmaceuticals ltd - morphine hydrochloride dihydrocodeine hydrochloride papaverine hydrochloride - solution for injection - 15.4, 1.2, milligram
caverject 20 micrograms powder and solvent for solution for injection
pfizer healthcare ireland - alprostadil - powder and solvent for solution for injection - 20 microgram(s) - drugs used in erectile dysfunction; alprostadil
caverject 10 micrograms powder and solvent for solution for injection
pfizer healthcare ireland - alprostadil - powder and solvent for solution for injection - 10 microgram(s) - drugs used in erectile dysfunction; alprostadil
niopam glass bottles 340 milligram solution for injection
bracco uk limited - iopamidol - solution for injection - 340 milligram
niopam 340, solution for injection, glass bottles
bracco imaging spa - iopamidol - solution for injection - 340 milligram(s) - watersoluble, nephrotropic, low osmolar x-ray contrast media; iopamidol
apomine apomorphine hydrochloride hemihydrate 100 mg/20 ml solution for infusion vial
interpharma pty ltd - apomorphine hydrochloride hemihydrate, quantity: 5 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium chloride; hydrochloric acid; water for injections - indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.
hypaque sodium- diatrizoate sodium injection, solution
amersham health inc. - diatrizoate sodium (unii: v5403h8vg7) (diatrizoic acid - unii:5uvc90j1lk) - injection, solution - 500 mg in 1 ml - hypaque sodium 50 percent is indicated for excretory urography, cerebral and peripheral angiography, aortography, intraosseous venography, direct cholangiography, hysterosalpingography, splenoportography, and contrast enhancement of computed tomographic head imaging. diatrizoate salts are used in small, medium, and large dose urography (see dosage and administration—excretory urography). visualization of the urinary tract can be achieved by either direct intravenous bolus injection, intravenous drip infusion, or incidentally following intra-arterial procedures.visualization of the urinary tract is delayed in infants less than 1 month old, and in patients with urinary tract obstruction (see clinical pharmacology). injectable radiopaque contrast media may be used to refine diagnostic precision in areas of the brain which may not otherwise have been satisfactorily visualized. radiopaque diagnostic agents may be useful to investigate the presence and extent of certain malignancies such as: gliomas including malig
hypaque sodium- diatrizoate meglumine injection, solution
amersham health inc. - diatrizoate meglumine (unii: 3x9mr4n98u) (diatrizoic acid - unii:5uvc90j1lk) - injection, solution - 60 g in 100 ml - hypaque meglumine 60 percent is indicated for excretory urography; cerebral angiography; peripheral arteriography; venography; operative, t-tube, or percutaneous transhepatic cholangiography; splenoportography; arthrography; discography; and contrast enhancement of computed tomographic head imaging. diatrizoate salts are used in small, medium, and large dose urography (see dosage and administration-excretory urography). visualization of the urinary tract can be achieved by either direct intravenous bolus injection, intravenous drip infusion, or incidentally following intra-arterial procedures. visualization of the urinary tract is delayed in infants less than 1 month old, and in patients with urinary tract obstruction (see clinical pharmacology). injectable radiopaque contrast media may be used to refine diagnostic precision in areas of the brain which may not otherwise have been satisfactorily visualized. radiopaque diagnostic agents may be useful to investigate the presence and extent of certain malignancie